Literature DB >> 28588712

Maximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.

Katsuyuki Shirai1, Takanori Abe1, Jun-Ichi Saitoh1, Tatsuji Mizukami1, Daisuke Irie1, Yosuke Takakusagi1, Shintaro Shiba1, Naoko Okano1, Takeshi Ebara2, Tatsuya Ohno1, Takashi Nakano1.   

Abstract

The present study (University Hospital Medical Information Network study no. UMIN000003797) aimed to evaluate whether the maximum standardized uptake value (SUVmax) of pretreatment 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) is prognostic factor for stage I non-small cell lung cancer (NSCLC) treated with carbon ion radiotherapy (C-ion RT). Patients treated between June 2010 and June 2013 at Gunma University Heavy Ion Medical Center (Maebashi, Japan) on a prospective protocol were included in the present study. Patients with T1a-b and T2a NSCLC were treated with C-ion RT at a dose of 52.8 Gy [relative biological effectiveness (RBE)] and 60.0 Gy (RBE), respectively, in four fractions. Prior to treatment, all patients underwent FDG-PET, in which the SUVmax of primary tumors was evaluated. Local control, progression-free survival (PFS), and overall survival (OS) were calculated. A total of 45 patients were analyzed and the median follow-up period was 28.9 months. The 2-year local control, PFS and OS rates for all patients were 93, 78 and 89%, respectively. The mean SUVmax of primary tumors was 5.5, and patients were divided into higher (≥5.5) and lower (<5.5) SUVmax groups. The 2-year PFS rates were 61 and 89% for the higher and lower SUVmax groups, respectively (P=0.01), and the 2-year OS rates for the higher and lower SUVmax groups were 76 and 96%, respectively (P=0.01). The higher SUVmax group exhibited a significantly worse PFS and OS compared with the lower SUVmax group; however, the SUVmax was not associated with the local control rate. In total, 2 patients (4%) experienced grade 2 or 3 radiation pneumonitis, with their symptoms improved through conservative treatment. No patients experienced any grade 4 or 5 toxicities. The results of the present study indicate that pretreatment SUVmax is a prognostic indicator for outcomes in patients with stage I NSCLC treated with C-ion RT.

Entities:  

Keywords:  18F-fluorodeoxyglucose-positron emission tomography; carbon ion radiotherapy; maximum standardized uptake value; prognostic factor; stage I non-small cell lung cancer

Year:  2017        PMID: 28588712      PMCID: PMC5452921          DOI: 10.3892/ol.2017.5952

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.

Authors:  Yoko Satoh; Hiroshi Onishi; Atsushi Nambu; Tsutomu Araki
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

Review 3.  Biological characteristics of carbon-ion therapy.

Authors:  Koichi Ando; Yuki Kase
Journal:  Int J Radiat Biol       Date:  2009-09       Impact factor: 2.694

4.  Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.

Authors:  Michael P Mac Manus; Rodney J Hicks; Jane P Matthews; Andrew Wirth; Danny Rischin; David L Ball
Journal:  Lung Cancer       Date:  2005-02-17       Impact factor: 5.705

5.  Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.

Authors:  Ali Salavati; Samuel Borofsky; Teo K Boon-Keng; Sina Houshmand; Benjapa Khiewvan; Babak Saboury; Ion Codreanu; Drew A Torigian; Habib Zaidi; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

6.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

7.  The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Authors:  Angela van Baardwijk; Christophe Dooms; Robert Jan van Suylen; Erik Verbeken; Monique Hochstenbag; Cary Dehing-Oberije; Dennis Rupa; Silvia Pastorekova; Sigrid Stroobants; Ulrich Buell; Philippe Lambin; Johan Vansteenkiste; Dirk De Ruysscher
Journal:  Eur J Cancer       Date:  2007-05-23       Impact factor: 9.162

8.  Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week.

Authors:  Tadaaki Miyamoto; Masayuki Baba; Toshio Sugane; Mio Nakajima; Tomoyasu Yashiro; Kennji Kagei; Naoki Hirasawa; Toshiyuki Sugawara; Naoyoshi Yamamoto; Masashi Koto; Hidefumi Ezawa; Kennoshuke Kadono; Hirohiko Tsujii; Jun-etsu Mizoe; Kyosan Yoshikawa; Susumu Kandatsu; Takehiko Fujisawa
Journal:  J Thorac Oncol       Date:  2007-10       Impact factor: 15.609

9.  Technical approach to individualized respiratory-gated carbon-ion therapy for mobile organs.

Authors:  Mutsumi Tashiro; Takayoshi Ishii; Jun-ichi Koya; Ryosuke Okada; Yuji Kurosawa; Keisuke Arai; Satoshi Abe; Yoshiaki Ohashi; Hirofumi Shimada; Ken Yusa; Tatsuaki Kanai; Satoru Yamada; Hidemasa Kawamura; Takeshi Ebara; Tatsuya Ohno; Takashi Nakano
Journal:  Radiol Phys Technol       Date:  2013-04-09

Review 10.  Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis.

Authors:  Feifei Na; Jingwen Wang; Cong Li; Lei Deng; Jianxin Xue; You Lu
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

View more
  9 in total

1.  Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.

Authors:  Sang Ho Lee; Andreas Rimner; Emily Gelb; Joseph O Deasy; Margie A Hunt; John L Humm; Neelam Tyagi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-03-02       Impact factor: 7.038

2.  Pretreatment 18F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.

Authors:  Guang Ma; Bingxin Gu; Jiyi Hu; Lin Kong; Jiangang Zhang; Zili Li; Yangbo Xue; Jiade Lu; Junning Cao; Jingyi Cheng; Yingjian Zhang; Shaoli Song; Zhongyi Yang
Journal:  Ann Nucl Med       Date:  2021-04-28       Impact factor: 2.668

3.  Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Authors:  Giulia Riva; Sara Imparato; Giovanni Savietto; Mattia Pecorilla; Alberto Iannalfi; Amelia Barcellini; Sara Ronchi; Maria Rosaria Fiore; Chiara Paganelli; Giulia Buizza; Mario Ciocca; Guido Baroni; Lorenzo Preda; Ester Orlandi
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

4.  Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.

Authors:  Katsuyuki Shirai; Motohiro Kawashima; Jun-Ichi Saitoh; Takanori Abe; Kyohei Fukata; Yuka Shigeta; Daisuke Irie; Shintaro Shiba; Naoko Okano; Tatsuya Ohno; Takashi Nakano
Journal:  PLoS One       Date:  2017-04-11       Impact factor: 3.240

5.  Correlation of quantified metabolic activity in nonsmall cell lung cancer with tumor size and tumor pathological characteristics.

Authors:  Mehrdad Bakhshayesh Karam; Abtin Doroudinia; Bahareh Behzadi; Payam Mehrian; Abbas Yousefi Koma
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

6.  Carbon-ion Radiotherapy for Isolated Lymph Node Metastasis After Surgery or Radiotherapy for Lung Cancer.

Authors:  Katsuyuki Shirai; Yoshiki Kubota; Tatsuya Ohno; Jun-Ichi Saitoh; Takanori Abe; Tatsuji Mizukami; Yasumasa Mori; Hidemasa Kawamura; Keiko Akahane; Takashi Nakano
Journal:  Front Oncol       Date:  2019-08-07       Impact factor: 6.244

7.  Efficacy of a combined tool for stage I non-small cell lung cancer against lymph node metastasis.

Authors:  Takeo Nakada; Mitsuo Yabe; Takashi Ohtsuka
Journal:  Oncol Lett       Date:  2022-08-09       Impact factor: 3.111

8.  Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy.

Authors:  Suman Shrestha; Tetsuya Higuchi; Katsuyuki Shirai; Azusa Tokue; Shreya Shrestha; Jun-Ichi Saitoh; Hiromi Hirasawa; Tatsuya Ohno; Takashi Nakano; Yoshito Tsushima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-22       Impact factor: 9.236

9.  Differentiation between non-small cell lung cancer and radiation pneumonitis after carbon-ion radiotherapy by 18F-FDG PET/CT texture analysis.

Authors:  Makito Suga; Ryuichi Nishii; Kenta Miwa; Yuto Kamitaka; Kana Yamazaki; Kentaro Tamura; Naoyoshi Yamamoto; Ryosuke Kohno; Masato Kobayashi; Katsuyuki Tanimoto; Hiroshi Tsuji; Tatsuya Higashi
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.